We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$3.85B
AUM Growth
+$562M
Cap. Flow
+$416M
Cap. Flow %
10.82%
Top 10 Hldgs %
23.4%
Holding
264
New
87
Increased
53
Reduced
31
Closed
84

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$153M
2
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$148M
3
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
+$75.5M
4
PM icon
Philip Morris
PM
+$68.9M
5
DIS icon
Walt Disney
DIS
+$68.2M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$84.9M
2
HST icon
Host Hotels & Resorts
HST
+$83.1M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$75.7M
4
WYNN icon
Wynn Resorts
WYNN
+$73M
5
BIIB icon
Biogen
BIIB
+$62.5M

Sector Composition

Rank Sector Weight
1 Communication Services 17.28%
2 Consumer Discretionary 16.94%
3 Financials 14.08%
4 Technology 13.04%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXLL
151
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$3.37M 0.09%
75,000
+50,000
+200% +$2.13M
HZNP
152
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.33M 0.09%
220,000
-110,000
-33% -$1.24M
RCL icon
153
Royal Caribbean
RCL
$86.8B
$3.27M 0.09%
60,000
-540,000
-90% -$27.4M
TNL icon
154
Travel + Leisure Co
TNL
$4.76B
$3.24M 0.08%
+98,036
New +$3.2M
TUES
155
DELISTED
Tuesday Morning Corp
TUES
$3.18M 0.08%
225,000
-125,000
-36% -$1.8M
BIIB icon
156
Biogen
BIIB
$30.9B
$3.06M 0.08%
10,010
-196,949
-95% -$62.5M
GPRE icon
157
Green Plains
GPRE
$1.15B
$3M 0.08%
100,000
+8,599
+9% +$211K
IPXL
158
DELISTED
Impax Laboratories, Inc.
IPXL
$2.8M 0.07%
106,132
-43,952
-29% -$1.1M
CASH icon
159
Pathward Financial
CASH
$1.88B
$2.67M 0.07%
178,371
+50,985
+40% +$713K
HUN icon
160
Huntsman Corp
HUN
$2.1B
$2.44M 0.06%
100,000
-618,902
-86% -$14.4M
XLRN
161
DELISTED
Acceleron Pharma
XLRN
$2.17M 0.06%
+63,000
New +$2.84M
SBH icon
162
Sally Beauty Holdings
SBH
$1.47B
$2.16M 0.06%
+78,701
New +$2.24M
HRTX icon
163
Heron Therapeutics
HRTX
$93.4M
$1.75M 0.05%
+125,663
New +$1.68M
ITCI
164
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.48M 0.04%
+81,231
New +$1.47M
BLUE
165
DELISTED
bluebird bio
BLUE
$1.37M 0.04%
+4,636
New +$1.4M
CMP icon
166
Compass Minerals
CMP
$1.23B
$1.24M 0.03%
+15,014
New +$1.24M
MNTA
167
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.14M 0.03%
97,400
+289
+0.3% +$4.89K
RTK
168
DELISTED
Rentech, Inc.
RTK
$949K 0.02%
+50,000
New +$929K
AMRN
169
Amarin Corp
AMRN
$297M
$679K 0.02%
+18,767
New +$698K
MWV
170
DELISTED
MEADWESTVACO CORP
MWV
$274K 0.01%
+7,300
New +$266K
AVDL
171
DELISTED
Avadel Pharmaceuticals
AVDL
$257K 0.01%
+19,151
New +$205K
WTS icon
172
Watts Water Technologies
WTS
$11.2B
$240K 0.01%
+4,100
New +$239K
ABEV icon
173
Ambev
ABEV
$47.9B
– –
-1,938,031
Closed -$14.2M
AJG icon
174
Arthur J. Gallagher & Co
AJG
$69.1B
– –
-59,709
Closed -$2.8M
AL
175
DELISTED
Air Lease Corp
AL
– –
-246,200
Closed -$7.65M
5 6
7
8 9

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Ascend Capital held 264 positions worth $3.85B, up 17% from $3.28B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital deployed $416M of net new capital in Q1 2014, opening 87 new positions and adding to 53 existing holdings. Its largest new stake was Verizon: 3,241,647 shares worth $154M.

By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 5.4% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $75.7M trimmed.

  • Ascend Capital's largest Q1 2014 buy was Verizon: 3,241,647 shares worth $154M.
  • Ascend Capital added most to Herc Holdings in Q1 2014, an estimated $53.3M increase.
  • Ascend Capital's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $75.7M.
  • Ascend Capital fully exited Marriott International in Q1 2014, selling an estimated $84.9M.
  • Ascend Capital's ten largest holdings make up 23% of its $3.85B portfolio in Q1 2014.
  • Ascend Capital opened 87 new positions and closed 84 in Q1 2014.
  • Ascend Capital's portfolio value rose 17% quarter-over-quarter to $3.85B.

Based on Ascend Capital's 13F filing for Q1 2014, filed 14 May 2014.